Simulations Plus, Inc. (NASDAQ:SLP) Receives $56.00 Average PT from Analysts

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $54.50.

SLP has been the topic of several recent research reports. BTIG Research lowered their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday. Craig Hallum restated a “buy” rating and set a $56.00 price objective on shares of Simulations Plus in a research note on Wednesday, July 3rd. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Thursday. KeyCorp initiated coverage on Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. Finally, JMP Securities began coverage on shares of Simulations Plus in a research note on Tuesday, July 16th. They set a “market perform” rating on the stock.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total value of $625,200.00. Following the sale, the director now directly owns 3,481,592 shares in the company, valued at approximately $108,834,565.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last quarter, insiders sold 60,750 shares of company stock valued at $2,145,055. Corporate insiders own 20.90% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Tributary Capital Management LLC boosted its position in Simulations Plus by 54.7% during the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after buying an additional 115,122 shares during the period. Silvercrest Asset Management Group LLC bought a new stake in shares of Simulations Plus in the 1st quarter valued at $4,717,000. Wasatch Advisors LP increased its position in shares of Simulations Plus by 36.5% during the first quarter. Wasatch Advisors LP now owns 381,693 shares of the technology company’s stock worth $15,707,000 after buying an additional 102,135 shares during the period. Dimensional Fund Advisors LP raised its stake in Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock worth $20,128,000 after buying an additional 37,992 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in Simulations Plus during the second quarter valued at $1,320,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Price Performance

SLP opened at $30.68 on Thursday. The business has a fifty day simple moving average of $33.08 and a 200 day simple moving average of $40.56. Simulations Plus has a 1 year low of $29.37 and a 1 year high of $51.22. The company has a market capitalization of $613.91 million, a PE ratio of 63.92 and a beta of 0.69.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The company had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. During the same quarter in the previous year, the business posted $0.18 earnings per share. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis. Equities analysts anticipate that Simulations Plus will post 0.54 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.